Upfront Genotyping of DPYD* 2A to Individualize Fluoropyrimidine Therapy: A Safety and Cost Analysis

MJ Deenen, Didier Meulendijks, A Cats, MK Sechterberger, Hans Severens, Henk Boot, PH Smits, Hilde Rossing, CMPW Mandigers, Marcel Soesan, JH Beijen, JHM Schellens

Research output: Contribution to journalArticleAcademicpeer-review

14 Downloads (Pure)
Original languageEnglish
JournalJournal of Clinical Oncology
Volume34
Issue number3
DOIs
Publication statusPublished - 2015

Research programs

  • EMC NIHES-05-63-02 Quality

Cite this